Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Mcgill University
Headquarters: Montreal, QC, Canada
Website: http://www.mcgill.ca
Year Founded: 1821
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Nov 29, 2023
Distillery Therapeutics
Small molecule NRF2 inhibitor for KEAP1-mutant lung cancer
BioCentury | Aug 11, 2023
Discovery & Translation
Bacteria to detect tumors; plus Netris’ mAb to block EMT in cancer and more
BioCentury’s roundup of translational innovations
BioCentury | Feb 9, 2022
Discovery & Translation
Translational trendspotting: a Distillery dive into infectious disease
Host targets, cross-reactive mAbs and COVID-19 countermeasures stand out in BioCentury’s Distillery
BioCentury | Sep 10, 2021
Targets & Mechanisms
Integrated stress response key to seemingly disparate diseases?
A flurry of preclinical studies builds the case for the integrated stress response as a central driver of many diseases
BioCentury | Aug 27, 2021
Distillery Therapeutics
Blocking unfolded protein response, integrated stress response for necrotizing fasciitis, lung cancer
BioCentury | Dec 2, 2020
Emerging Company Profile
Sofinnova’s Papiernik, Costa and Roche alum Garibaldi carve orphan neurology play Noema out of the pharma’s assets
Emerging Company Profile: Noema emerges from stealth with $59M to develop four clinical neurology programs in-licensed from Roche
BioCentury | Jun 6, 2020
Product Development
June 5 Quick Takes: Merck, Tetraphase-Melinta, Apeiron, Neurasic, Jounce, Genmab-J&J
BioCentury | Jun 4, 2020
Product Development
WHO restarts hydroxychloroquine testing as drug fails another COVID-19 trial
Editors flag ‘serious’ concerns regarding validity of data in Lancet paper
Items per page:
1 - 10 of 207